EPE248 | A shift from onsite to online dissemination of new WHO treatment guidelines for HIV and TB through short interactive courses for health workers. Is it cost effective? | E-poster | Assessments of cost effectiveness: Provider and community perspectives |
EPE249 | Affordability of integrating early childhood development into PMTCT programs | E-poster | Assessments of cost effectiveness: Provider and community perspectives |
EPE250 | Cost'benefit analysis of investments made in Morocco since the creation of the Global Fund (2002 - 2020) for HIV control | E-poster | Assessments of cost effectiveness: Provider and community perspectives |
PESUE25 | Optimal treatment and prevention mix for South Africa's UTT program | Poster exhibition | Assessments of cost effectiveness: Provider and community perspectives |
EPF045 | Analysing the role of stigma and racism in harm reduction policy: a tri-country analysis | E-poster | Availability and access to harm reduction (including OST and NSP) |
EPF046 | The need for overdose education and naloxone distribution among people who inject drugs in Kazakhstan | E-poster | Availability and access to harm reduction (including OST and NSP) |
PESUF22 | Evaluating legal obstacles to provider-assisted injection in Ontario's Supervised Consumption Services | Poster exhibition | Availability and access to harm reduction (including OST and NSP) |
EPD280 | Understanding participant motivation to participate in HIV prevention vaccine and monoclonal antibody trials in South Africa | E-poster | Behavioural factors impacting acceptability and uptake of an HIV vaccine |
EPD281 | A qualitative interview study to explore perceptions of a prophylactic vaccine for human immunodeficiency virus (HIV) | E-poster | Behavioural factors impacting acceptability and uptake of an HIV vaccine |
EPD282 | The moderating effect of HIV-stigma on the relationship between sources of perceived social support and self-efficacy among adult patients living with HIV, in KwaZulu-Natal, South Africa | E-poster | Behavioural factors impacting acceptability and uptake of an HIV vaccine |